Intellia Therapeutics, Inc. (NTLA): 4 filed Jan 7, 2026

Form type

4

Filing date

Jan 7, 2026

Accession number

0001193125-26-006288

Filer

Intellia Therapeutics, Inc. (CIK 1652130)